Ra Capital Management, L.P.'s Net Worth

Ra Capital Management, L.P.'s net worth is estimated to be at least $604,272,549.65 as of 05/23/2024. CoreStreet's estimation of Ra Capital Management, L.P.'s net worth is based on their sale of stock and current holding of stock.

Ra Capital Management, L.P. is Major Shareholder at Boundless Bio Inc. Common Stock. They have executed at least 68 trades of stock as per SEC Form 4 filings. Their most recent trade was for 312,500 units of BOLD stock on 04/02/2024. Their biggest sale was on 09/29/2020 when they sold 80,707 units of Vaxcyte Inc stock for $4,203,220.56. They typically trade 13 times per year.

Total value of insider buys:
  • $586,331,931.81
Total value of insider sells:
  • $17,940,617.84
Most recent insider trade:
  • April 2, 2024

Ra Capital Management, L.P.'s Insider Trading History

Boundless Bio Inc. Common StockTitleAmountPriceTypeTotal Value
April 2, 2024
Major Shareholder312,500$16.00Buy$5,000,000.00
Silverback Therapeutics IncTitleAmountPriceTypeTotal Value
March 27, 2024
Director505,954$9.79Buy$4,953,289.66
March 25, 2024
Director437,600$9.06Buy$3,964,656.00
Sept. 21, 2023
Director2,700,000$3.03Buy$8,181,000.00
Aug. 29, 2023
Director3,750,000$6.20Buy$23,250,000.00
LENZ Therapeutics IncTitleAmountPriceTypeTotal Value
March 21, 2024
Director998,009$15.03Buy$15,000,075.27
89bio IncTitleAmountPriceTypeTotal Value
March 4, 2024
Director1,350,000$15.35Buy$20,722,500.00
March 24, 2023
Director2,461,538$16.25Buy$39,999,992.50
Oct. 18, 2022
Director1,172,741$7.65Buy$8,971,468.65
July 1, 2022
Director2,816,900$3.55Buy$9,999,995.00
June 2, 2021
Director22,138$18.77Buy$415,530.26
May 28, 2021
Director123,505$18.77Buy$2,318,188.85
May 26, 2021
Director48,377$18.03Buy$872,237.31
Sept. 17, 2020
Director1,300,000$28.00Buy$36,400,000.00
July 8, 2020
Director275,000$27.50Buy$7,562,500.00
PepGen LtdTitleAmountPriceTypeTotal Value
Feb. 9, 2024
Director2,557,593$10.64Buy$27,212,789.52
Wave Life Sciences LtdTitleAmountPriceTypeTotal Value
Dec. 11, 2023
Director1,000,000$5.00Buy$5,000,000.00
June 16, 2022
Director9,480,052$2.15Buy$20,382,111.80
Acumen Pharmaceuticals IncTitleAmountPriceTypeTotal Value
July 21, 2023
Director5,161,290$7.75Buy$39,999,997.50
Janux Therapeutics IncTitleAmountPriceTypeTotal Value
July 19, 2023
Director495,008$12.46Buy$6,167,799.68
Dice Molecules Holdings LLCTitleAmountPriceTypeTotal Value
March 29, 2023
Director66,369$29.38Buy$1,949,921.22
March 27, 2023
Director151,132$27.48Buy$4,153,107.36
March 23, 2023
Director155,089$26.67Buy$4,136,223.63
Oct. 17, 2022
Director1,640,000$36.50Buy$59,860,000.00
Mineralys Therapeutics Inc. Common StockTitleAmountPriceTypeTotal Value
Feb. 14, 2023
Director1,250,000$16.00Buy$20,000,000.00
Fulcrum Therapeutics IncTitleAmountPriceTypeTotal Value
Jan. 20, 2023
Major Shareholder1,923,076$13.00Buy$24,999,988.00
Jan. 4, 2023
Major Shareholder180,703$7.28Buy$1,315,517.84
Dec. 27, 2022
Major Shareholder4,089$5.99Buy$24,493.11
Dec. 19, 2022
Major Shareholder98,787$5.90Buy$582,843.30
Dec. 16, 2022
Major Shareholder1,341,420$5.42Buy$7,270,496.40
Dec. 14, 2022
Major Shareholder824,600$5.46Buy$4,502,316.00
Werewolf Therapeutics IncTitleAmountPriceTypeTotal Value
Jan. 6, 2023
Director1,853,000$2.21Buy$4,095,130.00
May 4, 2021
Director1,715,000$16.00Buy$27,440,000.00
Imara IncTitleAmountPriceTypeTotal Value
Dec. 8, 2022
Major Shareholder10,600$3.75Buy$39,750.00
Oct. 24, 2022
Major Shareholder26,460$3.91Buy$103,458.60
Oct. 21, 2022
Major Shareholder48,100$3.92Buy$188,552.00
Oct. 19, 2022
Major Shareholder125,726$3.89Buy$489,074.14
Oct. 17, 2022
Major Shareholder145,672$3.36Buy$489,457.92
Acrivon Therapeutics, Inc. Common StockTitleAmountPriceTypeTotal Value
Nov. 17, 2022
Director3,389,500$12.50Buy$42,368,750.00
Kala Pharmaceuticals IncTitleAmountPriceTypeTotal Value
May 25, 2022
Major Shareholder1,434,509$0.42Sell$602,493.78
May 23, 2022
Major Shareholder1,250,000$0.65Sell$812,500.00
Nkarta IncTitleAmountPriceTypeTotal Value
April 26, 2022
Director2,200,000$15.00Buy$33,000,000.00
Icosavax IncTitleAmountPriceTypeTotal Value
March 28, 2022
Director175,318$4.53Buy$794,190.54
Cytek Biosciences IncTitleAmountPriceTypeTotal Value
March 14, 2022
Director342,143$12.35Buy$4,225,466.05
March 11, 2022
Director337,492$12.77Buy$4,309,772.84
March 9, 2022
Director40,154$12.99Buy$521,600.46
March 7, 2022
Director337,901$12.61Buy$4,260,931.61
March 4, 2022
Director63,662$12.99Buy$826,969.38
March 2, 2022
Director138,255$12.89Buy$1,782,106.95
Feb. 28, 2022
Director8,746$12.97Buy$113,435.62
Feb. 24, 2022
Director186,467$13.03Buy$2,429,665.01
Feb. 22, 2022
Director214,922$13.46Buy$2,892,850.12
Feb. 18, 2022
Director166,229$14.12Buy$2,347,153.48
Feb. 16, 2022
Director166,200$14.98Buy$2,489,676.00
Feb. 14, 2022
Director166,229$14.72Buy$2,446,890.88
Solid Biosciences LLCTitleAmountPriceTypeTotal Value
March 19, 2021
Director2,206,685$5.75Buy$12,688,438.75
Rhythm Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Dec. 2, 2020
Major Shareholder30,939$32.39Sell$1,002,114.21
July 1, 2020
Major Shareholder25,527$21.87Sell$558,275.49
June 29, 2020
Major Shareholder52,049$22.19Sell$1,154,967.31
June 25, 2020
Major Shareholder11,568$25.05Sell$289,778.40
Pmv Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Sept. 29, 2020
Major Shareholder950,000$18.00Buy$17,100,000.00
Vaxcyte IncTitleAmountPriceTypeTotal Value
Sept. 29, 2020
Major Shareholder80,707$52.08Sell$4,203,220.56
TG Therapeutics IncTitleAmountPriceTypeTotal Value
Sept. 9, 2020
Major Shareholder158,589$25.81Sell$4,093,182.09
Verastem IncTitleAmountPriceTypeTotal Value
June 25, 2020
Major Shareholder1,161,300$1.91Sell$2,218,083.00
April 27, 2020
Major Shareholder1,301,300$2.31Sell$3,006,003.00
Phathom Pharmaceuticals IncTitleAmountPriceTypeTotal Value
March 31, 2020
Major Shareholder30,600$24.55Buy$751,230.00
March 27, 2020
Major Shareholder30,000$24.60Buy$738,000.00
Scpharmaceuticals IncTitleAmountPriceTypeTotal Value
Feb. 14, 2020
Major Shareholder271,993$8.20Buy$2,230,342.60